View Future GrowthDispensa Group 과거 순이익 실적과거 기준 점검 0/6지난 몇 년간 Dispensa Group 의 실적에 대한 데이터가 부족합니다.핵심 정보n/a순이익 성장률n/a주당순이익(EPS) 성장률Consumer Retailing 산업 성장률10.52%매출 성장률n/a자기자본이익률-12.77%순이익률-59.63%최근 순이익 업데이트28 Feb 2023최근 과거 실적 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Mar 19Dispensa Group Announces Cancellation of Trading of Ordinary Shares on the Main Market for Listed Securities of the London Stock ExchangeFurther to the announcements made on 16 February and 14 March 2024, Dispensa Group Plc announced that the listing of the company's Ordinary Shares on the Official List of the Financial Conduct Authority and admission to trading on the Main Market for listed securities of the London Stock Exchange plc have now been cancelled with effect from 8.00 a.m. (London time) 19 March 2024.공시 • Feb 17Dispensa Group Plc, Annual General Meeting, Mar 14, 2024Dispensa Group Plc, Annual General Meeting, Mar 14, 2024, at 11:00 Coordinated Universal Time. Location: 50 Sloane Avenue, London SW3 3DD SW3 3DD London United Kingdom공시 • Feb 14Dispensa Intends to Delist its Ordinary Shares from the U.K.'s Financial Conduct Authority's Official List, and Cancel its Listing on the London Stock ExchangeDispensa Group Plc said it intends to delist its ordinary shares from the U.K.'s Financial Conduct Authority's official list, and cancel its listing on the London Stock Exchange. The e-commerce and retail technology company--formerly known as Zamaz--said the decision aims to maximize shareholder value and increase the company's potential for long-term success. The board said the challenges behind the implementation of its growth-acquisition strategy in a listed environment, the considerable management time and cost of remaining listed at this stage of the company's development, as well as current market conditions, were key factors behind the decision. The company also said that its strategy of buying undervalued, traditional premium brand businesses and digitizing their systems and processes to increase revenue, margins and value, is more suited to a private equity environment focusing "on longer-term initiatives, without the shorter-term reporting timelines of public equity markets." Dispensa said it will send out a circular setting out further details of the delisting, and its implications, by February 16. "The company also notes that the delisting would enable it to make numerous cost savings to the benefit of Shareholders and that it will implement a cost efficiency program should the delisting be approved," it said.New Risk • Feb 08New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €7.92m (US$8.53m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (20% average weekly change). Market cap is less than US$10m (€7.92m market cap, or US$8.53m). Minor Risk Latest financial reports are more than 6 months old (reported February 2023 fiscal period end).New Risk • Jan 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 9.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported February 2023 fiscal period end). Share price has been volatile over the past 3 months (9.1% average weekly change). Market cap is less than US$100m (€18.6m market cap, or US$20.2m).Buying Opportunity • Dec 16Now 24% undervalued after recent price dropOver the last 90 days, the stock is down 24%. The fair value is estimated to be €0.046, however this is not to be taken as a buy recommendation but rather should be used as a guide only.공시 • Nov 23Dispensa Group Plc Announces Chief Executive Officer ChangesDispensa Group Plc announced that Mr. Alessandro Colombo is stepping down from his role as Chief Executive Officer for pressing personal reasons and has agreed with the Company that he will leave with immediate effect. Mr. Daniele Besnati has been re-appointed Interim Chief Executive Officer, a role he held immediately prior to Mr. Colombo's appointment. A further announcement regarding a new permanent appointment will be made in due course.Board Change • Oct 31Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non-Executive Chairman Niccolo Caderni was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Oct 20Dispensa Group plc Appoints Alessandro Colombo as CEO with Immediate EffectDispensa Group plc announced the appointment of Mr. Alessandro Colombo as CEO with immediate effect. Mr. Colombo, 56, is a highly experienced executive who has held senior leadership positions within both public and private companies as General Manager and CEO. Most recently, Mr. Colombo was the Area General Manager for Italy at Sonder, a leading hospitality group, where he was responsible for strategy and operations as well as delivering record revenue growth. Prior to this, Mr. Colombo was Chief Executive Officer at IKB Corporate Lab, a joint-venture between UniCredit and IKB in the financial sector, and a Vice President in investment banking at Credit Suisse First Boston, where he advised corporate clients on corporate strategy, M&A and fundraisings. Mr. Colombo has also worked as a corporate finance manager at Swiss insurance company, Assura S.A. and as a management consultant for McKinsey & Co. An Italian national, Mr. Colombo speaks five languages, and has experience of working across mainland Europe and in the UK. He holds a degree in Economics from Bocconi and an MBA from the University of California, Los Angeles. Mr. Colombo's current and past directorships are as follows: Past five years: Sonder Italy S.r.l., special attorney (legal representative) from December 10, 2018 until June 30, 2023 Director from October 28, 2019 until November 21, 2019.공시 • Aug 24Zamaz plc Announces Board ChangesZamaz plc announced that Dr Niccolò Caderni, previously a Non-Executive Director of the Company, has been appointed Non-Executive Chairman with immediate effect. The previous Chairman, Martin Groak has moved to a Non-Executive Director role and remains as chairman of the Audit Committee.매출 및 비용 세부 내역Dispensa Group가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이DB:K7L 매출, 비용 및 순이익 (GBP Millions)날짜매출순이익일반관리비연구개발비28 Feb 234-33030 Nov 223-22031 Aug 222-120양질의 수익: K7L 은(는) 현재 수익성이 없습니다.이익 마진 증가: K7L는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: K7L은 상장된 지 3년이 되지 않아 지난 5년간 전년 대비 수익 증가율이 긍정적인지 확인할 수 없습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 K7L의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: K7L은 수익성이 없어 지난 해 수익 성장률을 Consumer Retailing 업계(2.1%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: K7L는 현재 수익성이 없으므로 자본 수익률이 음수(-12.77%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YConsumer-retailing 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/03/21 14:34종가2024/03/21 00:00수익2023/02/28연간 수익2022/08/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Dispensa Group Plc는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Mar 19Dispensa Group Announces Cancellation of Trading of Ordinary Shares on the Main Market for Listed Securities of the London Stock ExchangeFurther to the announcements made on 16 February and 14 March 2024, Dispensa Group Plc announced that the listing of the company's Ordinary Shares on the Official List of the Financial Conduct Authority and admission to trading on the Main Market for listed securities of the London Stock Exchange plc have now been cancelled with effect from 8.00 a.m. (London time) 19 March 2024.
공시 • Feb 17Dispensa Group Plc, Annual General Meeting, Mar 14, 2024Dispensa Group Plc, Annual General Meeting, Mar 14, 2024, at 11:00 Coordinated Universal Time. Location: 50 Sloane Avenue, London SW3 3DD SW3 3DD London United Kingdom
공시 • Feb 14Dispensa Intends to Delist its Ordinary Shares from the U.K.'s Financial Conduct Authority's Official List, and Cancel its Listing on the London Stock ExchangeDispensa Group Plc said it intends to delist its ordinary shares from the U.K.'s Financial Conduct Authority's official list, and cancel its listing on the London Stock Exchange. The e-commerce and retail technology company--formerly known as Zamaz--said the decision aims to maximize shareholder value and increase the company's potential for long-term success. The board said the challenges behind the implementation of its growth-acquisition strategy in a listed environment, the considerable management time and cost of remaining listed at this stage of the company's development, as well as current market conditions, were key factors behind the decision. The company also said that its strategy of buying undervalued, traditional premium brand businesses and digitizing their systems and processes to increase revenue, margins and value, is more suited to a private equity environment focusing "on longer-term initiatives, without the shorter-term reporting timelines of public equity markets." Dispensa said it will send out a circular setting out further details of the delisting, and its implications, by February 16. "The company also notes that the delisting would enable it to make numerous cost savings to the benefit of Shareholders and that it will implement a cost efficiency program should the delisting be approved," it said.
New Risk • Feb 08New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €7.92m (US$8.53m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (20% average weekly change). Market cap is less than US$10m (€7.92m market cap, or US$8.53m). Minor Risk Latest financial reports are more than 6 months old (reported February 2023 fiscal period end).
New Risk • Jan 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 9.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported February 2023 fiscal period end). Share price has been volatile over the past 3 months (9.1% average weekly change). Market cap is less than US$100m (€18.6m market cap, or US$20.2m).
Buying Opportunity • Dec 16Now 24% undervalued after recent price dropOver the last 90 days, the stock is down 24%. The fair value is estimated to be €0.046, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
공시 • Nov 23Dispensa Group Plc Announces Chief Executive Officer ChangesDispensa Group Plc announced that Mr. Alessandro Colombo is stepping down from his role as Chief Executive Officer for pressing personal reasons and has agreed with the Company that he will leave with immediate effect. Mr. Daniele Besnati has been re-appointed Interim Chief Executive Officer, a role he held immediately prior to Mr. Colombo's appointment. A further announcement regarding a new permanent appointment will be made in due course.
Board Change • Oct 31Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non-Executive Chairman Niccolo Caderni was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Oct 20Dispensa Group plc Appoints Alessandro Colombo as CEO with Immediate EffectDispensa Group plc announced the appointment of Mr. Alessandro Colombo as CEO with immediate effect. Mr. Colombo, 56, is a highly experienced executive who has held senior leadership positions within both public and private companies as General Manager and CEO. Most recently, Mr. Colombo was the Area General Manager for Italy at Sonder, a leading hospitality group, where he was responsible for strategy and operations as well as delivering record revenue growth. Prior to this, Mr. Colombo was Chief Executive Officer at IKB Corporate Lab, a joint-venture between UniCredit and IKB in the financial sector, and a Vice President in investment banking at Credit Suisse First Boston, where he advised corporate clients on corporate strategy, M&A and fundraisings. Mr. Colombo has also worked as a corporate finance manager at Swiss insurance company, Assura S.A. and as a management consultant for McKinsey & Co. An Italian national, Mr. Colombo speaks five languages, and has experience of working across mainland Europe and in the UK. He holds a degree in Economics from Bocconi and an MBA from the University of California, Los Angeles. Mr. Colombo's current and past directorships are as follows: Past five years: Sonder Italy S.r.l., special attorney (legal representative) from December 10, 2018 until June 30, 2023 Director from October 28, 2019 until November 21, 2019.
공시 • Aug 24Zamaz plc Announces Board ChangesZamaz plc announced that Dr Niccolò Caderni, previously a Non-Executive Director of the Company, has been appointed Non-Executive Chairman with immediate effect. The previous Chairman, Martin Groak has moved to a Non-Executive Director role and remains as chairman of the Audit Committee.